ABSTRACT Selective extraction of the adenylate cyclase regulatory protein (N-protein) from pigeon erythrocyte plasma membranes provided evidence for its cytoskeletal association. Cholate, but not Triton X-100 or digitonin, was effective in solubilizing the ADP-ribosylated N-protein. The labeled protein complex or components thereof that were associated with the Triton-insoluble cytoskeleton (shells) could be partly released by 0.1 mM EDTA; 1 M KCI in the presence of Triton X-100 achieved complete solubilization. 5'-Guanylyl imidodiphosphate (p[NH]ppG) and NaF, activators of adenylate cyclase, promoted the release of the regulatory protein from the cytoskeleton but MnC12, an "uncoupler" of the adenylate cyclase system, had the opposite effect. The solubilized, labeled N-protein was able to bind specificially to rat eryth-ocyte inside-out vesicles in the presence of divalent cations. A proteolytic product of inside-out vesicles inhibited the binding of the N-protein to fresh vesicles. Three molecular species which contained the Mr 45,000 polypeptide component of the N-protein were identified by gel permeation chromatography and by sucrose density gradient velocity sedimentation. p[NH]ppG appeared to convert the two larger molecular complexes to a smaller molecular entity. Such a molecular dissociation might be relevant to the effects of guanyl nucleotides on the activity of adenylate cyclase and on the affinity of hormone receptors.
Activation ofthe adenylate cyclase system by hormones or GTP analogs appears to involve changes in the molecular associations among the receptor, the regulatory nucleotide-binding protein (N-protein), and the catalytic component. Gel permeation chromatography (1), sucrose density gradient sedimentation (2, 3) , and target-irradiation analysis (4) have provided evidence for these molecular changes. Furthermore, selective extraction (5) and reconstitution (6) experiments suggested that constituents of the adenylate cyclase complex were bound to the cytoskeleton in a manner that depended on the state of activation of the enzyme (6) . This report focuses on several molecular interactions of the N-protein and on their regulation by agents that activate adenylate cyclase. We have also attempted to solubilize, separate, and characterize the putative molecular complexes that result from these interactions. This approach may help to elucidate further the mechanism of activation of the enzyme as well as the mechanism of the regulation ofthe number and the affinity of hormone receptors that act on adenylate cyclase.
Our results indicate that the N-protein binds to the inner aspect ofthe plasma membrane, partly through specific proteinprotein interactions. 5'-Guanyl imidodiphosphate p[NH]ppG and NaF appear to release the N-protein from the cytoskeleton, whereas MnCl2, which "uncouples" the regulatory component from the catalytic component (7) , seems to increase the association between the N-protein and the cytoskeleton. Three different molecular complexes which contain the ADP-ribosylated (8) . Erythrocytes were obtained from male SpragueDawley rats (125-150 g) and from White Carneau pigeons. Rat reticulocytes were produced by the phenylhydrazine injection method (1) . Pigeon erythrocytes were lysed by freeze-thawing, and the plasma membrane fraction was separated as reported (9) . Rat reticulocyte and erythrocyte ghosts were made by hypotonic lysis (10) and they were resealed in the presence of MgCl2 (11) . Inside-out vesicles were prepared by incubation of the erythrocyte ghosts in 0.1 mM sodium phosphate buffer (pH 7.6) at 37°C (12) . The N-protein of erythrocyte ghosts and plasma membranes was labeled by ADP-ribosylating the Mr 45,000 polypeptide in the presence ofcholera toxin and 60 ;LM [a-32P]NAD (5) (6) (7) Ci/mmol) (9) ; 65-80% ofthe total membrane protein ADP-ribosylation was accounted for by the specific labeling of the Mr 45,000 polypeptide.
Sucrose density gradients (5-20%) were prepared in cellulose nitrate tubes. The gradients contained 25 mM Tris-HCl (pH 7.6), 0.1% Triton X-100 (all detergent concentrations are expressed as wt/vol), and 5 mM MgCl2. Samples (0.2 ml) were loaded and the gradients were centrifuged in a Beckman SW 50.1 rotor at 45,000 rpm for [14] [15] [16] hr at 40C, and 0.2-ml fractions were collected. Gel permeation chromatography was performed by applying 0.5-ml samples to 26-ml Ultrogel AcA-34 columns and elutingwith 50 mM Tris-HCl, pH 7.6/0.1% Triton X-100/5 mM MgCl2; 0.8-ml fractions were collected. The buffers used in all experiments contained 30 pig of phenylmethylsulfonyl fluoride per ml.
The labeled Mr 45,000 polypeptide contained in the fractions from the sucrose density gradients and from the AcA-34 columns was separated from other membrane proteins by NaDodSO4/polyacrylamide gel electrophoresis; the gels were then subjected to autoradiography with the assistance of a fluorescent screen (5 20 vol of 2.0% Triton X-100/5 mM MgCl2 for 30 min at 00C. The resulting detergent shells were resuspended in buffer (0.6 mg of protein per ml) and then were extracted for 30 min as follows: A, 1.0% Triton X-100 at 00C; B, 1.0% Triton X-100 at 370C; C, 0.1 mM EDTA, pH 7.6, at 370C; D, 1 M KI at 00C; and E, 1 M KCI/0.5% Triton X-100 at 00C. All extraction media (except C) contained 50 mM Tris HCl (pH 7.6). The 160,000 x gm. supernatants were assayed for the labeled Mr 45,000 polypeptide.
55% was solubilized by Triton X-100 or digitenin. The sol'ibilization characteristics of adenylate cyclase, the Mr 45,000 polypeptide and other membrane proteins are compared elsewhere (5) .
The subpopulation of the Mr 45,000 polypeptide that remained associated with the detergent shells after maximal extraction with Triton X-100 at 0C could be solubilized further (Fig. 2) The labeled Mr 45,000 polypeptide was solubilized from pigeon erythrocyte plasma membranes with 0.5% Triton X-100 at 0°C. The reaction mixture was incubated at 23°C for 30 min, and then chilled and centrifuged at 36,000 x gm. over 15% sucrose in a Microfuge tube (14) .
The resulting pellets were subsequently assayed for the amount of bound Mr 45,000 polypeptide. Treatment of the inside-out vesicles with trypsin was performed by exposing the vesicles (2.8 mg of protein per ml) to trypsin at 10 pg/ml for 15 min at0°C; the proteolysis was stopped by adding soybean trypsin inhibitor. Trypsin that had been preincubated with soybean trypsin inhibitor was used in a control incubation.
The soluble (160,000 x gm supernatant) products of the trypsin treatment were used to block the binding of the Mr 45,000 polypeptide.
Under the conditions of the assay, the binding was complete after 20 min at 230C. The binding was also linear with respect to the amount of rat erythrocyte membrane vesicles used (80-170 ug) and with respect to the amount of labeled Mr 45,000 polypeptide (50-150 fmol). Table 1 . Sedimentation and sample analysis were performed as in Fig. 4 . *, Control. lecular complexes. The Stokes radii and the sedimentation coefficients were a function of the method of solubilization. Extraction of detergent shells with Triton X-100 at 37C released the largest macromolecular complex; treatment of the plasma membranes with 0.1 mM EDTA (pH 7.6) at 37°C produced the smallest. Solubilization of plasma membranes with Triton X-100 at 0°C resulted in the release of an intermediatesize molecular species. This material was also produced by treatment with cholate or 1 M KC1 in the presence ofTriton X-100 at 0°C. Incubation of the material corresponding to the intermediate-size peak at 370C for 30 min did not yield either of the the other two peaks, implying that the differences in the molecular complexes were not due solely to differences in the temperature of extraction. p[NH]ppG, but not NaF, treatment followed by detergent extraction induced a shift to a molecular form with a smaller sedimentation coefficient (Fig. 5) . A similar p[NH]ppG-induced shift in sedimentation properties has been noted by others (2, 3). A 26-ml AcA-34 column was used to characterize this p[NH]ppG effect further. Solubilization of p[NH]ppG-pretreated membranes with Triton X-100 at 0°C produced a labeled molecular entity that eluted 1.6 ml after the labeled material solubilized from control membranes (data not shown).
DISCUSSION
The development ofspecific reconstitution (16) (17) (18) (19) and labeling (8, 18, 20) techniques has resulted in a better understanding of the adenylate cyclase system. We had previously detected both a particulate and a soluble guanyl nucleotide-binding protein (N-protein) which mediated the activation of adenylate cyclase by guanyl nucleotides in several rat tissues (16, 17) . In addition, we also demonstrated a reversible interaction between this protein and p[NH]ppG, leading to a conformational change in the N-protein which altered its sensitivity to proteolysis and thermal inactivation (17) . This activated N-protein formed a highaffinity complex with a catalytic component, resulting in the activation of adenylate cyclase (17) . Affinity chromatography (18) and somatic cell variants (19) have also been used to isolate and characterize the N-protein. Moreover, a multisubunit form of the protein (Mr 130,000) has recently been detected (21) and purified (15) . In this communication we characterized the interaction of the N-protein with other membrane components and provide evidence for the possible functional significance of these interactions.
Several findings suggest a functional interaction between the N-protein and the cytoskeleton: (a) the protein is associated with Triton and digitonin shells and is solubilized with 0.1 mM EDTA; (b) cholate and 1 M KCl (in the presence of Triton X-100), which solubilize the Mr 45,000 polypeptide efficiently, are also known to solubilize certain cytoskeletal components (22, 23) ; (c) the N-protein has been shown to bind detergent poorly and to be largely exposed to the inner aspect of the plasma membrane (21, 24) . Furthermore, the present results provide evidence for the occurrence of a specific proteinaceous site on the cytoplasmic surface of erythrocyte plasma membranes which binds the N-protein in a divalent cation-dependent reaction. This binding site may be involved in the association between the N-protein and the cytoskeleton.
The cytoskeletal interactions of the N-protein seem to correlate with its state of activation. The effects of p[NH]ppG, GTP, and NaF are consistent with a weakening of this interaction. In contrast, MnCl2, which uncouples the N-protein from the catalytic component (7), promotes this interaction. The aforementioned uncoupling may also be due to the effect of MnCL2 on other membrane proteins which are also rendered more resistant to detergent solubilization by MnC12.
The separation of three molecular species that contain the ADP-ribosylated Mr 45,000 polypeptide indicates that this polypeptide is a constituent of a multicomponent molecular complex. The largest molecular form derived from Triton shells may include one or more cytoskeletal elements. The intermediate molecular entity appears to be similar in size to that reported earlier (21) and purified subsequently (15 (17, 28) . The recent determination of the subunit structure of the N-protein (15) should facilitate further elucidation of these molecular changes.
Based on the foregoing discussion, the following sequence of reactions that leads to the activation of adenylate cyclase by p[NH]ppG is suggested: N' ). The G-N' complex dissociates readily after the removal of free G (17) . However, G-N' binds tightly to the catalytic component of adenylate cyclase (E) to produce the active state of the enzyme (17) . The velocity sedimentation and gel permeation results indicate that N' is larger than the Mr 45,000 polypeptide. Accordingly, it is possible that N' dissociates further to the Mr 45,000 polypeptide prior to interacting with the catalytic component. This possibility is consistent with the observed change in the size ofadenylate cyclase after its activation by p[NH]ppG (26, 27) . In addition to its role in activating adenylate cyclase, Biochemistry: Sahyoun et aL 6162 Biochemistry: Sahyoun et aL G-N' may also be the entity responsible for the effect ofguanyl nucleotides on receptor affinity. Furthermore, the activated enzyme binds to M to form a relatively high-affinity complex (6) . This may serve to sequester an active enzyme pool or it may play a role in the inactivation limb (not shown).
Molecular interactions involving the cytoskeleton also appear to regulate the -adrenergic receptor. We recently found an association between a subpopulation of this receptor and digitoning shells of rat erythrocytes (unpublished data). Moreover, agonists, but not antagonists, seem to release the receptor from the cytoskeletal constraints, suggesting that this reaction may be required for hormone action (29) . Thus, activation of both the N-protein and the f3adrenergic receptor may involve the dissociation of each of these components from its cytoskeletal binding site.
